Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzaetype b vaccine; Infanrix™ hexa

Immune memory to hepatitis B virus in 4-to-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine

(2014) Michael Zinke et al.   Human vaccines & immunotherapeutics

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Improving adherence rates to a cocooning program

(2013) Andrea Simonetti et al.   Human Vaccines & Immunotherapeutics

Seroepidemiology of Polioviruses among University Students in Northern Italy

(2012) Vincenzo Baldo et al.   Clinical and Vaccine Immunology

Hospitalizations for pertussis in Italy, 1999–2009: analysis of the hospital discharge database

(2012) Giovanni Gabutti et al.   EUROPEAN JOURNAL OF PEDIATRICS

Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

(2012) Lara K. Misegades et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Feasibility of a Cocoon Strategy for the Prevention of Pertussis in Italy

(2012) Rosa Prato et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, Tetanus, Acellular Pertussis Hepatitis B–inactivated Poliovirus at 3, 5 and 11 Months of Age

(2012) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Reanalyses of case-control studies examining the temporal association between sudden infant death syndrome and vaccination

(2012) Ronny Kuhnert et al.   VACCINE

Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age

(2012) Olivier Van Der Meeren et al.   VACCINE

Sudden Unexpected Deaths and Vaccinations during the First Two Years of Life in Italy: A Case Series Study

(2011) Giuseppe Traversa et al.   PLoS One

An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children

(2011) Markus Knuf et al.   VACCINE

Ten years of Hib vaccination in Italy: Prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance

(2011) Maria Giufrè et al.   VACCINE

Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance

(2011) Lennart Nilsson et al.   VACCINE

Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease

(2010) HANS O. HALLANDER et al.   APMIS

Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life

(2010) Michael Steiner et al.   BMC INFECTIOUS DISEASES

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers

(2010) S. Esposito et al.   Clinical and Vaccine Immunology

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

(2010) Jussi Mertsola et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzaetype b vaccines administered at 3, 5 and 11–12 months of age

(2010) Terhi M. Kilpi et al.   Human vaccines & immunotherapeutics

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

(2010) Y. Poovorawan et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study

(2010) Alessandro Remo Zanetti et al.   LANCET INFECTIOUS DISEASES

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

(2010) Robert Booy et al.   VACCINE

Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe

(2010) Timo Vesikari et al.   VACCINE

Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience

(2009) Hans O Hallander et al.   Expert Review of Vaccines

Review of 8 years of experience with Infanrix hexa™ (DTPa–HBV–IPV/Hib hexavalent vaccine)

(2009) Fred Zepp et al.   Expert Review of Vaccines

Impact of a Pentavalent Combination Vaccine on Immunization Timeliness in a State Medicaid Population

(2009) Laura E. Happe et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy

(2009) Paolo Durando et al.   VACCINE

Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand

(2009) Yong Poovorawan et al.   VACCINE

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

(2008) Cristina Giambi et al.   BMC INFECTIOUS DISEASES

Effectiveness of hexavalent vaccines against invasive Haemophilus influenzae type b disease: Germany's experience after 5 years of licensure

(2008) Helen Kalies et al.   VACCINE